Tsai T J, Chen Y M, Yeah F T, Hsieh B S, Chen W Y, Yen T S
Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, R.O.C.
J Formos Med Assoc. 1991 Jan;90(1):105-8.
To investigate the response of urinary active and inactive kallikrein excretion to sodium depletion in golmerulonephritic (GN) patients, we measured the excretion of urinary active and inactive kallikreins in 10 primary GN patients before and after a low sodium (17 mEq/day), constant potassium (40 mEq/day) diet. They ranged in age from 24 to 47 years with 7 men and 3 women. The etiology included 4 IgA nephropathy, 4 mesangial proliferative GN, 1 minimal change disease and 1 focal sclerosis. The active urinary kallikrein activity was measured by assay of its enzymatic activity on synthetic chromogenic substrate S-2266. The urinary inactive kallikrein excretion was determined indirectly by substracting active kallikrein activity from total kallikrein activity. The latter was measured after trypsin activation of inactive kallikrein. The results showed a significant increase in total and active urinary kallikrein excretion following a low salt diet. Yet, the inactive urinary kallikrein excretion and the ratio of active/total kallikrein excretion showed no significant change. There was no correlation between active and inactive urinary kallikrein excretion either before or after a low sodium, constant potassium diet. These findings suggest that the renal kallikrein-kinin system of GN patients responds normally to the stimulation of sodium depletion.
为研究肾小球肾炎(GN)患者尿中活性和非活性激肽释放酶排泄对钠缺失的反应,我们测量了10例原发性GN患者在低钠(17 mEq/天)、恒定钾(40 mEq/天)饮食前后尿中活性和非活性激肽释放酶的排泄情况。他们年龄在24至47岁之间,7名男性,3名女性。病因包括4例IgA肾病、4例系膜增生性GN、1例微小病变病和1例局灶节段性肾小球硬化。尿中活性激肽释放酶活性通过检测其对合成发色底物S - 2266的酶活性来测定。尿中非活性激肽释放酶排泄量通过从总激肽释放酶活性中减去活性激肽释放酶活性间接确定。后者在非活性激肽释放酶经胰蛋白酶激活后测量。结果显示低盐饮食后尿中总激肽释放酶和活性激肽释放酶排泄量显著增加。然而,尿中非活性激肽释放酶排泄量以及活性/总激肽释放酶排泄量的比值无显著变化。在低钠、恒定钾饮食前后,尿中活性和非活性激肽释放酶排泄量之间均无相关性。这些发现提示GN患者的肾激肽释放酶 - 激肽系统对钠缺失刺激反应正常。